Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12607]

ASH 2014: Phase II trial shows maintenance with ixazomib in newly diagnosed multiple myeloma may be feasible

ASH 2014: Phase II trial shows maintenance with ixazomib in newly diagnosed multiple myeloma may be feasible

ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer patients

ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer...

ASH 2014: Anticoagulation after incidental pulmonary embolism may reduce risk of clot recurrence in cancer patients

ASH 2014: Anticoagulation after incidental pulmonary embolism may reduce risk of clot recurrence in cancer patients

ASH 2014: Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia

ASH 2014: Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia

ASH 2014: Chemo-free treatment approach demonstrates positive responses in leukaemia patients

ASH 2014: Chemo-free treatment approach demonstrates positive responses in leukaemia patients

ASH 2014: Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial

ASH 2014: Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase...

ASH 2014: Sotarcept reduces transfusion burden in patients with myelodysplastic syndromes

ASH 2014: Sotarcept reduces transfusion burden in patients with myelodysplastic syndromes

ASH 2014: New immunotherapy compound effective and safe in leukaemia patients with minimal residual disease

ASH 2014: New immunotherapy compound effective and safe in leukaemia patients with minimal residual disease

ASH 2014: Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study

ASH 2014: Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III...

ASH 2014: Stem cell transplantation safe for patients with HIV-associated lymphoma

ASH 2014: Stem cell transplantation safe for patients with HIV-associated lymphoma

More from ecancer